Several studies suggested a molecular mechanism of the development of cancer-associated thrombocytosis which can be explained by the ability of some cancer cell types to produce thrombopoietin (TPO), a key cytokine stimulating megakaryocyte differentiation and proliferation and resultant platelet production. The gene discussed is TPO; the disease is cancer.